Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Candidiasis,Inverse variance weighted,41,1.01 [0.90-1.14],0.825696791875711
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,41,1.06 [1.01-1.11],0.0152464994516294
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,41,1.05 [1.01-1.09],0.0134999408469289
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,41,0.99 [0.91-1.07],0.738300028967896
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,41,1.04 [0.99-1.08],0.0870589973168
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,41,1.68 [1.12-2.54],0.0131856246731901
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,41,0.96 [0.90-1.03],0.214088984312216
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,41,1.27 [0.74-2.17],0.389127551112916
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,Inverse variance weighted,41,1.00 [0.92-1.08],0.900170793982681
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,41,1.07 [0.87-1.32],0.498195065006665
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,Inverse variance weighted,41,1.11 [0.99-1.26],0.0760181727894369
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,41,1.03 [0.85-1.25],0.76781705656407
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,Inverse variance weighted,41,0.97 [0.86-1.09],0.625520795477346
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,41,1.00 [0.73-1.37],0.99582100050727
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,41,1.00 [0.93-1.07],0.925771334019518
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,41,1.07 [1.00-1.14],0.0381425245660934
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,Inverse variance weighted,41,0.90 [0.71-1.13],0.361236404194214
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,Inverse variance weighted,41,0.88 [0.58-1.34],0.554039600405357
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,41,1.02 [0.90-1.14],0.775904079398104
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,41,0.99 [0.85-1.15],0.882842905151993
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,41,0.97 [0.86-1.10],0.668545675040177
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,Inverse variance weighted,41,0.97 [0.82-1.14],0.691293266150686
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,41,1.06 [0.78-1.43],0.717240777591729
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,Inverse variance weighted,41,0.93 [0.79-1.08],0.331800680630567
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,Inverse variance weighted,41,0.94 [0.83-1.07],0.354939715094355
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,41,0.93 [0.79-1.09],0.37396851313392
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,41,0.94 [0.81-1.08],0.347191042689683
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,41,0.96 [0.90-1.01],0.12793751331662
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,41,0.94 [0.88-1.01],0.0896072407097588
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,41,0.91 [0.79-1.03],0.143039229517302
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,41,0.97 [0.81-1.15],0.703304170141945
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,Inverse variance weighted,41,0.94 [0.86-1.03],0.209823700609328
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,Inverse variance weighted,41,1.02 [0.91-1.15],0.741446473671084
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,41,0.93 [0.85-1.03],0.157086554719523
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,41,0.98 [0.95-1.01],0.249912423325866
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,41,1.08 [0.93-1.24],0.304126960142209
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,Inverse variance weighted,41,0.96 [0.88-1.04],0.300904273642758
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",Inverse variance weighted,41,1.08 [0.65-1.82],0.757320881614982
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,41,1.00 [0.97-1.03],0.954406883308844
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,41,1.11 [0.97-1.27],0.120344619323598
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",Inverse variance weighted,41,0.88 [0.77-1.01],0.0670632898576503
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,Inverse variance weighted,41,1.03 [0.99-1.08],0.128629973435183
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,Inverse variance weighted,41,1.03 [0.99-1.08],0.1269095954502
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,41,1.04 [1.01-1.07],0.0052653973140671
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,Inverse variance weighted,41,1.02 [0.99-1.04],0.246637154011085
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,Epilepsy,Inverse variance weighted,41,1.05 [0.99-1.12],0.106524387819504
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,Hemiplegia,Inverse variance weighted,41,0.99 [0.84-1.17],0.908821321883561
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,Other neurological diseases,Inverse variance weighted,41,1.01 [0.96-1.05],0.78821904825617
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,41,1.05 [0.96-1.16],0.270847713907872
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,41,0.95 [0.85-1.05],0.284507167565505
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,41,0.99 [0.93-1.04],0.619131002908505
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,41,0.89 [0.78-1.02],0.0844371772448717
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,41,1.06 [0.99-1.14],0.106957374972859
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,41,1.15 [0.98-1.34],0.0887891692556128
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",Inverse variance weighted,41,0.94 [0.80-1.10],0.4435872157455
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,41,0.98 [0.92-1.05],0.62570597198577
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,41,0.99 [0.94-1.05],0.778917680746231
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,41,1.01 [0.91-1.11],0.922918208285653
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,41,1.07 [0.69-1.65],0.768630327891555
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,41,0.94 [0.75-1.18],0.609960355457067
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,41,0.89 [0.75-1.07],0.217519377132132
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,41,0.95 [0.75-1.20],0.646539759858073
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,41,0.94 [0.81-1.11],0.47966854580361
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,DVT of lower extremities,Inverse variance weighted,41,0.95 [0.88-1.03],0.240064367682297
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),Inverse variance weighted,41,0.95 [0.87-1.04],0.298283634958867
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Right bundle-branch block,Inverse variance weighted,41,0.99 [0.80-1.23],0.96255044082056
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,41,1.12 [0.86-1.45],0.402303687325153
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,41,1.01 [0.83-1.24],0.88979913289794
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,Inverse variance weighted,41,0.97 [0.90-1.04],0.321525980641822
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,41,1.08 [0.88-1.34],0.447301733794405
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,Other disorders of veins,Inverse variance weighted,41,0.96 [0.89-1.03],0.236903015072091
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,41,1.14 [1.01-1.29],0.0400808273726753
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),Inverse variance weighted,41,1.02 [0.93-1.12],0.624190217344439
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,41,1.17 [0.98-1.39],0.0770445201988806
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,41,1.15 [1.03-1.28],0.0100333889564798
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Bronchiectasis,Inverse variance weighted,41,1.11 [0.95-1.31],0.198585757024762
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,Inverse variance weighted,41,0.98 [0.87-1.09],0.663810184943026
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,All influenza,Inverse variance weighted,41,1.02 [0.95-1.10],0.568791465302631
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,41,1.02 [0.98-1.06],0.349170822570805
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,41,1.03 [1.00-1.06],0.0872981149505055
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,41,1.05 [1.00-1.10],0.0591589192943288
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,41,1.04 [0.98-1.10],0.20870442275752
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,41,1.04 [0.94-1.16],0.448291498021671
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,Inverse variance weighted,41,1.04 [0.89-1.22],0.601775835210587
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,Pulmonary oedema,Inverse variance weighted,41,1.01 [0.74-1.37],0.950090896273266
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,Inverse variance weighted,41,1.02 [0.97-1.08],0.387866718624091
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,41,1.02 [0.88-1.17],0.791364979726633
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Cholelithiasis,Inverse variance weighted,41,1.03 [0.97-1.09],0.304672619339324
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Constipation,Inverse variance weighted,41,1.02 [0.98-1.06],0.385409309615993
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,41,1.00 [0.91-1.09],0.935718676671335
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,41,1.05 [0.98-1.12],0.180487801281207
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,41,1.05 [0.90-1.23],0.508388620139799
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,41,0.94 [0.75-1.16],0.549158473391794
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,41,1.03 [1.01-1.06],0.0176076522196792
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,41,1.04 [0.97-1.11],0.250572377333421
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,41,1.02 [0.97-1.06],0.459519233975546
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Diseases of the digestive system,Inverse variance weighted,41,1.06 [1.00-1.12],0.0345503008017459
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,Inverse variance weighted,41,1.07 [1.00-1.15],0.0352049459135268
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,Inverse variance weighted,41,0.98 [0.87-1.11],0.782362292492577
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,Inverse variance weighted,41,1.03 [0.88-1.20],0.710547345838668
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,41,1.09 [0.99-1.20],0.0899644096745176
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,41,1.00 [0.95-1.06],0.952512232409069
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,41,1.03 [0.94-1.14],0.514791678683351
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,Inverse variance weighted,41,1.09 [0.93-1.28],0.266600398886678
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Acute peritonitis,Inverse variance weighted,41,1.03 [0.87-1.23],0.716812724601375
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,Diseases of peritoneum,Inverse variance weighted,41,0.96 [0.83-1.11],0.562528890601017
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",Inverse variance weighted,41,1.04 [1.00-1.08],0.0515959156992302
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,41,1.03 [1.01-1.06],0.0186184367739502
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,41,1.04 [0.96-1.13],0.356637242053581
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,41,1.14 [0.93-1.40],0.202669702783582
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,41,1.00 [0.96-1.05],0.912305784180409
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,Inverse variance weighted,41,1.02 [0.79-1.33],0.853191111714229
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,41,0.98 [0.94-1.03],0.425700038425134
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,41,1.05 [0.94-1.17],0.40956995504079
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,41,1.02 [0.98-1.05],0.351779416299201
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,Inverse variance weighted,41,1.03 [0.99-1.07],0.200647122999237
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,41,1.00 [0.94-1.07],0.989157017379364
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,Inverse variance weighted,41,1.06 [0.98-1.16],0.158579814385019
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,Inverse variance weighted,41,1.02 [0.99-1.05],0.266695466345385
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",Inverse variance weighted,41,1.03 [0.99-1.06],0.106190549515153
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,41,0.97 [0.90-1.05],0.474845552123077
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,Inverse variance weighted,41,1.00 [0.95-1.06],0.858821026264231
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,41,1.00 [0.95-1.06],0.861972072955439
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,Inverse variance weighted,41,0.99 [0.81-1.22],0.94663578502021
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,Inverse variance weighted,41,1.02 [0.93-1.12],0.682043067238003
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,Inverse variance weighted,41,1.03 [0.99-1.07],0.166197035745442
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,41,1.01 [0.97-1.06],0.612257220817653
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,41,1.01 [0.95-1.08],0.723707211767578
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],Inverse variance weighted,41,1.02 [0.87-1.19],0.820029186713308
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,Inverse variance weighted,41,1.00 [0.97-1.03],0.919172624310091
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,Inverse variance weighted,41,0.85 [0.71-1.01],0.0655490276153973
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,41,0.99 [0.95-1.04],0.718534335374299
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,Inverse variance weighted,41,1.07 [1.02-1.12],0.0067821229376958
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,Inverse variance weighted,41,1.05 [0.99-1.11],0.0780229485690757
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,41,0.97 [0.89-1.06],0.497512789271038
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,41,0.94 [0.73-1.19],0.591012240770901
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,41,0.96 [0.88-1.04],0.29179650379098
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,41,0.91 [0.74-1.13],0.396278170403214
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,41,0.97 [0.86-1.09],0.57559890909582
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,41,0.87 [0.78-0.97],0.0141333367878512
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,Inverse variance weighted,41,0.85 [0.51-1.42],0.537005142781273
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,41,1.01 [0.98-1.05],0.456698312473923
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,41,1.12 [0.98-1.28],0.082759581333863
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",Inverse variance weighted,41,1.13 [0.98-1.31],0.0904698002696136
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,41,1.00 [0.96-1.04],0.938550451913714
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,41,1.00 [0.97-1.04],0.816784542541775
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,41,1.04 [0.94-1.16],0.437140534993484
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,41,1.03 [0.95-1.13],0.458990700876301
